Ignite Creation Date:
2024-05-05 @ 11:34 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00088101
Status:
COMPLETED
Last Update Posted:
2008-12-04
First Post:
2004-07-20
Brief Title:
STA-5312 Administered on Alternate Weekdays Every Two Weeks to Patients With Hematologic Malignancies and Patients With Solid Tumors
Sponsor:
Synta Pharmaceuticals Corp
Organization:
Synta Pharmaceuticals Corp